So the drug companies' $1.32 billion estimate was off, according to Light and Warburton, by only $977 million. Let's call it a rounding error.
The Five-Year IP Roadmap Is Over: How to Build an IP Strategy for a Future
You Can’t Predict
-
Long-lived patents, an AI-shifted landscape: why a fixed filing roadmap
fails, and the three decision rules an IP strategy needs instead.
5 days ago

No comments:
Post a Comment